COVID-19 has impacted communities all across our state, and every one of us plays a part in slowing the spread of the virus. Protecting our neighbors from COVID-19 is a personal responsibility — and getting the vaccine is a personal choice.
Find updates and information surrounding the COVID-19 vaccine so you can make an informed choice when the vaccine becomes available to you at oklahoma.gov/covid19/vaccine-information.html.
The health of Oklahoma National Guard members and their families is a key priority for the OKNG. Service members and their families are encouraged to sign up to receive vaccines at the earliest time they can.
To register to receive the vaccine, visit vaccinate.oklahoma.gov.
Before the U.S. Food and Drug Administration determines whether to approve a vaccine or authorize a vaccine for emergency use, clinical trials are conducted to determine how well it works. This is known as effectiveness.
After FDA approves a vaccine or authorizes a vaccine for emergency use, it continues to be studied to determine how well it works under real-world conditions. CDC and other federal partners will be assessing COVID-19 vaccine effectiveness under real-world conditions.
Learn how the CDC and FDA ensure vaccines are effective before they are administered at cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness.html.
The U.S. Food and Drug Administration has granted Emergency Use Authorizations for two COVID-19 vaccines which have been shown to be safe and effective as determined by data from the manufacturers and findings from large clinical trials. These data demonstrate that the known and potential benefits of this vaccine outweigh the known and potential harms of becoming infected with the coronavirus disease 2019.
Learn how the CDC and FDA ensure vaccines are safe before they are administered at cdc.gov/coronavirus/2019-ncov/vaccines/safety.html.
Now that there are authorized and recommended vaccines to prevent COVID-19 in the United States, Here are eight things you need to know about the new COVID-19 Vaccination Program and COVID-19 vaccines.
When the Food and Drug Administration authorizes or approves a COVID-19 vaccine, the Advisory Committee on Immunization Practices will quickly hold a public meeting to review all available data about that vaccine. Before making recommendations, ACIP reviews all available clinical trial information, including descriptions of:
Learn about the ethical principles and frameworks the CDC and ACIP uses when making vaccine recommendations at cdc.gov/coronavirus/2019-ncov/vaccines/recommendations-process.html.
Read this Fact Sheet at fda.gov/media/144414/download for information about the Pfizer-BioNTech COVID-19 Vaccine. Talk to the vaccination provider if you have questions. It is your choice to receive the Pfizer-BioNTech COVID-19 Vaccine. The Pfizer-BioNTech COVID-19 Vaccine is administered as a 2-dose series, 3 weeks apart, into the muscle.